clinical trial endpoint for locally advanced head and neck squamous cell carcinoma (hnscc)
Published 2 years ago • 2.4K plays • Length 4:39:32Download video MP4
Download video MP3
Similar videos
-
6:31
fda d.i.s.c.o.: fda approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
-
59:05
oncochallenge in locally advanced head and neck cancer: exploring new directions
-
56:50
exploring clinical trials in head and neck cancer webinar
-
3:35
clinical trial: squamous cell cancers of the head & neck - robert chin, md | ucla radiation oncology
-
1:36:15
conversations on cancer: clinical trial site selection: fact vs fiction
-
1:07:36
clinical trials and immunotherapy for head and neck cancer
-
33:15
optimizing the management of squamous cell carcinoma of the head and neck with immunotherapeutic ...
-
1:21
new squamous cell carcinoma clinical trial: bms-986340 for squamous cell carcinoma of head and neck
-
0:51
dr. machiels on pembrolizumab and chemoradiation in hnscc
-
1:03:08
clinical trials for sarcoma and head & neck cancers at yale
-
0:53
clinical trials evaluating immune checkpoint blockade and radiotherapy in head and neck cancer
-
5:42
case 1: treatment options for locally advanced cscc
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
1:09
the future role of immunotherapy in head and neck cancers
-
11:49
fda's pfdd initiative - road to clinical trial endpoints
-
7:59
fda approval in head and neck cancer, european approval in nsclc, and more
-
2:00
nectin-4 is widely expressed in head and neck squamous cell carcinoma | oncotarget
-
4:42
pembrolizumab for recurrent head and neck squamous cell carcinomas (hnscc)
-
4:06
immunotherapy for head and neck cancer treatment